Veterinary & Animal Health
Companion animal clinics, emergency veterinary hospitals, equine practices, and animal health pharmaceutical companies serving veterinary markets.
- 4
- Segments
- 16
- Verticals
Overview
Veterinary & Animal Health covers the animal-health industry — veterinary diagnostics and laboratories, animal-health pharmaceuticals and vaccines, equine and large-animal veterinary care, and livestock and agricultural animal health. It is the industrial and product side of animal care, distinct from the consumer-facing companion-animal practices tracked separately.
Pet humanization has driven strong, high-margin growth in companion-animal pharmaceuticals and diagnostics, while production-animal health is more mature and pressured by antibiotic-reduction trends. The sector is consolidated around global strategics (Zoetis, Boehringer Ingelheim, Elanco, Merck Animal Health) and a diagnostics duopoly (IDEXX, Antech), with active M&A.
Market snapshot
The veterinary-services code (NAICS 541940, ~$63B) is tracked under Consumer (Veterinary Services); this sector emphasizes diagnostics, animal pharmaceuticals, and production-animal health, which sit in laboratory, pharmaceutical, and agricultural classifications and are not separately sized here.
Business model & economics
Revenue model
Product sales (pharma, diagnostics) and specialized veterinary services
Key economics
- Recurring revenue
- High
- EBITDA margin
- Strong for diagnostics and companion-animal pharma
- Capex intensity
- High
recurring diagnostics, vaccines, and medications
Characteristics
- Pet humanization driving companion-animal pharma/diagnostics growth.
- Diagnostics a high-margin duopoly (IDEXX, Antech).
- Production-animal health more mature and pressured.
Geographic concentration
Veterinary care tracks pet ownership and livestock — distributed nationally with a rural, large-animal-practice tilt — while animal-health pharmaceutical operations cluster in New Jersey and Massachusetts.
U.S. Census Bureau — 2022 Statistics of U.S. Businesses (firms by state); veterinary services track population, while animal-health manufacturing concentration (NJ/MA) is shown by location quotient.
M&A deal context
Who’s acquiring
- Animal-health strategics (Zoetis et al.)
- Diagnostics & lab consolidators
- PE-backed animal-health platforms
What’s driving deals
- Companion-animal pharma and diagnostics growth.
- Consolidation around global animal-health strategics.
- Acquisition of diagnostics and novel-therapy innovation.
Segments in this industry
Find Veterinary & Animal Health acquisition targets
Search Acquisera’s index for companies classified under Veterinary & Animal Health (4.11) and build a targeted deal pipeline.
Search companies